Pyxis Oncology PYXS
NASDAQ PYXS
$1.80 -0.04 (-1.90%)
As of: Oct 21, 2026 · 11:40 AM EDT

Pyxis Oncology (PYXS) Other financing activities (2021 - 2025)

Updated

Pyxis Oncology (PYXS) recorded Other financing activities of $71,000 in Q4 2025, up 787.5% from the prior quarter.

Analysis

Pyxis Oncology (PYXS) Other financing activities (2021 - 2025) Analysis & Trends

For FY2025, Pyxis Oncology reported Other financing activities of $148,000, down 38.3% from FY2024.

  • Across earlier years, Other financing activities came in at $240,000 in FY2024 (-46.1%) and $445,000 in FY2023.
  • The Q4 2025 figure is the highest quarterly Other financing activities since Q1 2024.
  • Per Business Quant, the preceding three quarters came in at $8,000 (Q3 2025), $67,000 (Q2 2025) and $2,000 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn
10 Pyxis Oncology 116.14 Mn -148.91 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -71,000.00
Sep 30, 2025 -8,000.00
Jun 30, 2025 -67,000.00
Mar 31, 2025 -2,000.00
Sep 30, 2024 -1,000.00
Jun 30, 2024 -43,000.00
Mar 31, 2024 -196,000.00
Dec 31, 2023 -52,000.00
Sep 30, 2021 -1.72 Mn
Jun 30, 2021 -682,000.00
Mar 31, 2021 -47,000.00
API Access

Pyxis Oncology Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=PYXS&period=max&api_key=YOUR_API_KEY